1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Onychomycosis Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease Type
6.1 Distal Subungual Onychomycosis
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Proximal Subungual Onychomycosis
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 White Superficial Onychomycosis
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Candidal Onychomycosis
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Treatment Type
7.1 Laser Therapy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Photodynamic Therapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Drug Treatment
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Drug Class
8.1 Allylamine
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Azole
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Griseofulvin
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Online Stores
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Retail Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bausch Health Companies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Cipla Limited
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Dr. Reddy’s Laboratories
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Galderma SA
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlaxoSmithKline PLC
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Kaken Pharmaceutical Co. Ltd
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7 Lumenis Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 SWOT Analysis
15.3.8 Moberg Pharma AB
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Novartis AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 The OTC Lab B.V.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
世界の爪真菌症治療市場予測2022年-2028年 |
| 【英語タイトル】Onychomycosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 | |
 | ・商品コード：IMARC23FE0089 ・発行会社（調査会社）：IMARC ・発行日：2023年2月1日 ・ページ数：145 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール ・調査対象地域：グローバル ・産業分野：医療 |
| Single User | USD2,999 ⇒換算￥455,848 | 見積依頼/購入/質問フォーム |
| Five User | USD3,999 ⇒換算￥607,848 | 見積依頼/購入/質問フォーム |
| Enterprisewide | USD4,999 ⇒換算￥759,848 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| IMARC社は、2022年31億ドルであった世界の爪真菌症治療市場規模が2028年には43億ドルに達し、予測期間中、年平均5.37％成長すると予測しています。当調査資料では、爪真菌症治療の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、疾患タイプ別（遠位爪下爪真菌症、近位爪下爪真菌症、白色表在性爪真菌症、カンジダ性爪真菌症、その他）分析、治療タイプ別（レーザー治療、光線力学的療法、薬物療法）分析、薬物クラス別（アリルアミン、アゾール、グリセオフルビン、その他）分析、流通チャネル別（病院＆クリニック、オンラインストア、小売薬局、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、Bausch Health Companies Inc.、Cipla Limited、Dr. Reddy's Laboratories、Galderma SA、GlaxoSmithKline PLC、Kaken Pharmaceutical Co. Ltd、Lumenis Ltd、Moberg Pharma AB、Novartis AG、Pfizer Inc. and The OTC Lab B.V.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の爪真菌症治療市場規模：疾患タイプ別 - 遠位爪下爪真菌症の市場規模 - 近位爪下爪真菌症の市場規模 - 白色表在性爪真菌症の市場規模 - カンジダ性爪真菌症の市場規模 - その他疾患タイプの市場規模 ・世界の爪真菌症治療市場規模：治療タイプ別 - レーザー治療の市場規模 - 光線力学的療法の市場規模 - 薬物療法の市場規模 ・世界の爪真菌症治療市場規模：薬物クラス別 - アリルアミンの市場規模 - アゾールの市場規模 - グリセオフルビンの市場規模 - その他薬物クラスの市場規模 ・世界の爪真菌症治療市場規模：流通チャネル別 - 病院＆クリニックの市場規模 - オンラインストアの市場規模 - 小売薬局の市場規模 - その他流通チャネルの市場規模 ・世界の爪真菌症治療市場規模：地域別 - 北米の爪真菌症治療市場規模 - アジア太平洋の爪真菌症治療市場規模 - ヨーロッパの爪真菌症治療市場規模 - 中南米の爪真菌症治療市場規模 - 中東/アフリカの爪真菌症治療市場規模 ・SWOT分析 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 ・主要企業情報 |
The global onychomycosis treatment market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.37% during 2023-2028.
Onychomycosis is a fungal infection that occurs in the fingernails and toenails that can lead to discomfort, chronic pain and disfigurement. Proximal subungual, white superficial and distal subungual are some of the types of onychomycosis. It is a common nail infection in patients with athlete’s foot and is caused by various organisms, such as dermatophytes, yeasts and non-dermatophyte molds. Onychomycosis is characterized by symptoms, including distortion in the shape of nails, foul smell, whitish to yellow-brown discoloration and brittle, ragged and crumbly texture of the nails. It is usually diagnosed through potassium, oxygen and hydrogen (KOH) examination, culture and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs and photodynamic therapies.
Onychomycosis Treatment Market Trends:
The increasing prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes and peripheral artery disease (PAD), is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is providing a thrust to the market growth. Onychomycosis is also highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated or soiled clothes, shoes and socks. Additionally, the development of water-soluble antifungal treatment solutions that can be administered orally is providing a thrust to the market growth. They aid in preventing secondary bacterial infections and prevent the growth of fungus. Other factors, including the widespread utilization of topical nail lacquers and ointments to maintain nail hygiene, along with the significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global onychomycosis treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease type, treatment type, drug class and distribution channel.
Breakup by Disease Type:
Distal Subungual Onychomycosis
Proximal Subungual Onychomycosis
White Superficial Onychomycosis
Candidal Onychomycosis
Others
Breakup by Treatment Type:
Laser Therapy
Photodynamic Therapy
Drug Treatment
Breakup by Drug Class:
Allylamine
Azole
Griseofulvin
Others
Breakup by Distribution Channel:
Hospitals and Clinics
Online Stores
Retail Pharmacies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cipla Limited, Dr. Reddy’s Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.
Key Questions Answered in This Report
1. What was the size of the global onychomycosis treatment market in 2022?
2. What is the expected growth rate of the global onychomycosis treatment market during 2023-2028?
3. What are the key factors driving the global onychomycosis treatment market?
4. What has been the impact of COVID-19 on the global onychomycosis treatment market?
5. What is the breakup of the global onychomycosis treatment market based on the disease type?
6. What is the breakup of the global onychomycosis treatment market based on the treatment type?
7. What is the breakup of the global onychomycosis treatment market based on the distribution channel?
8. What are the key regions in the global onychomycosis treatment market?
9. Who are the key players/companies in the global onychomycosis treatment market?
❖ レポートの目次 ❖
| ★調査レポート[世界の爪真菌症治療市場予測2022年-2028年] (コード：IMARC23FE0089)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の爪真菌症治療市場予測2022年-2028年]についてメールでお問い合わせ |
